Dairy farmers looking for information and guidance on how herd monitoring technologies can help to improve their herd’s health, fertility and productivity can register for a series of free-to-attend webinars in July and August.
The ‘Digital Dairy Herd’ webinars are being hosted by Farmers Guardian in conjunction with MSD Animal Health and will be chaired by Farmers Guardian and Dairy Farmer editor, Katie Jones. Speakers will include Dr Stephanie Small, Veterinary Advisor for Technology for MSD Animal Health, as well as three UK dairy farmers, each of whom will explain how they are using MSD Animal Health’s SenseHub Dairy system to monitor and improve performance of their adult dairy cows, youngstock and heifers.
“The latest generation of herd monitoring systems offers much more beyond basic heat detection or rumination assessment in adult dairy cows,” Dr Small explains. “Systems such as SenseHub Dairy capture data at all stages in the dairy animal’s life, including from birth to 12 months, and can provide a huge amount of information regarding how each individual animal, or group of animals, is performing.
“But with so much information available, and with a lot of users only scratching the surface in terms of what these technologies can offer, the aim of the webinars is to shed more light onto how herd monitoring systems can be used to make better management decisions which not only improve animal health, welfare and performance, but which also benefit the working lives of the farm’s human resources.”
The webinars will focus on three key stages in the dairy cow’s lifecycle: improving the fertility, health and productivity of adult dairy cows, using technology to detect, prevent and
monitor health issues in dairy youngstock, and managing the health and fertility of heifers as they transition into the milking herd.
The webinars are scheduled to take place on the following dates (click on the links to register):
· The digital dairy herd: using technology to enhance adult cow performance https://webinars.farmersguardian.com...d-ep1/register
Thursday 8th July, 7pm;
· The digital dairy herd: using technology to enhance dairy youngstock performance https://webinars.farmersguardian.com...d-ep2/register
Thursday 22nd July, 7pm;
· The digital dairy herd: using technology to enhance dairy heifer performance https://webinars.farmersguardian.com...d-ep3/register
Thursday 5th August, 7pm.
The webinar recordings will be available to watch ‘on demand’ for those who miss the scheduled events.
About MSD Animal Health
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is a global animal health business committed to The Science of Healthier Animals™. For more than 130 years, we have pioneered groundbreaking science. Today, we are driven by continuous innovation to develop breakthrough medicines, vaccines and technology. Rooted in direct experience on the farm and in the clinic, we work hand in hand with our customers every step of the way. Our singular focus is to empower those who care for animals, helping them manage their vital responsibility with confidence. Because when it comes to animal health, no one sees it like we do. For more information, visit www.msd-animal-health.com and connect with us on LinkedIn and X (formerly Twitter).
Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2025 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
Attached Files